LifeTech Scientific (HKSE:01302) Long-Term Capital Lease Obligation : HK$3 Mil (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is LifeTech Scientific Long-Term Capital Lease Obligation?

LifeTech Scientific's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$3 Mil.

LifeTech Scientific's quarterly Long-Term Capital Lease Obligation declined from Dec. 2022 (HK$5 Mil) to Jun. 2023 (HK$4 Mil) and declined from Jun. 2023 (HK$4 Mil) to Dec. 2023 (HK$3 Mil).

LifeTech Scientific's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (HK$6 Mil) to Dec. 2022 (HK$5 Mil) and declined from Dec. 2022 (HK$5 Mil) to Dec. 2023 (HK$3 Mil).

LifeTech Scientific Long-Term Capital Lease Obligation Historical Data

The historical data trend for LifeTech Scientific's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeTech Scientific Long-Term Capital Lease Obligation Chart

LifeTech Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

12.83

5.54

5.66

5.18

3.29

LifeTech Scientific Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															5.66	3.53	5.18	4.00	3.29

LifeTech Scientific (HKSE:01302) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

LifeTech Scientific Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of LifeTech Scientific's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

LifeTech Scientific (HKSE:01302) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LifeTech Scientific Corp (HKSE:01302) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

LFTSF:USA 81X:Germany

Address

No. 22, Keji 12th Road South, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063

Website

http://www.lifetechmed.com

LifeTech Scientific Corp develops and manufactures minimally invasive medical devices for cardiovascular and vascular diseases. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.

Executives

Xie Yuehui	2201 Interest of corporation controlled by you
Xianjian Advanced Technology Limited	2101 Beneficial owner
Hhlr Advisors, Ltd.	2102 Investment manager
Bank Of Communications Trustee Limited	2301 Trustee
Xie Yuehui	2201 Interest of corporation controlled by you
Hhlr Fund, L.p.	2101 Beneficial owner
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Gaoling Fund, L.p.	2101 Beneficial owner

LifeTech Scientific (HKSE:01302) Headlines

No Headlines